Obesity is a growing concern worldwide, including in low- and middle-income countries (LMICs). Addressing this issue involves various strategies, including dietary and lifestyle changes, medical ...
Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced its ...
19h
New Scientist on MSNNew type of brain cell may tell us when to stop eatingNeurons in the brains of mice tell them to stop eating when they’ve had enough food – and since people probably have the same ...
A recent review shows who newer medications for type 2 diabetes may help the most, particularly in reducing the risk of cardiovascular disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results